New studies unravel mysteries of how PARP enzymes work

February 16, 2017

A component of an enzyme family linked to DNA repair, stress responses, and cancer also plays a role in enhancing or inhibiting major cellular activities under physiological conditions, new research shows.

The UT Southwestern Medical Center research focused on PARP-1, a member of the PARP enzyme family. Short for poly (ADP-ribose) polymerase, PARP became the focus of attention in 2014 with approval of the first PARP inhibitor drug to treat advanced ovarian cancer associated with mutant BRCA DNA repair genes. The drug, Lynparza or olaparib, blocks nuclear PARP enzymes, inhibiting DNA repair even further and causing genome instability that kills the cancer cells.

In two related studies published in Molecular Cell, UT Southwestern scientists describe how PARP-1 can act at a molecular level under physiological conditions to reduce the formation of fat cell precursors and to help maintain the unique ability of embryonic to self-renew and become any of a variety of different cell types. One of the studies is published online today; the earlier study posted Jan. 19.

PARP-1's role in these cellular processes occurs during gene transcription, when DNA is copied into messenger RNA molecules, which can then be used as a template to produce new proteins.

Researchers already knew about PARP's role in DNA damage-related diseases like cancer, said Dr. W. Lee Kraus, senior author of both UTSW studies and Professor of Obstetrics and Gynecology, and Pharmacology at UT Southwestern. Dr. Kraus also directs the Cecil H. and Ida Green Center for Reproductive Biology Sciences and holds the Cecil H. and Ida Green Distinguished Chair in Reproductive Biology Sciences.

These findings take the field in a new direction, Dr. Kraus said.

"Our research shows that PARP-1 also plays a role in normal physiological processes and normal cellular functions. It's an important component of the cellular machinery that senses and responds to the environment," he said.

While studies in mouse models show PARP-1 is not essential for life, it becomes important when an organism needs to adapt to changing environmental or physiological cues, such as developmental processes or altered diet, Dr. Kraus said.

Understanding how PARP-1 works could one day help researchers find ways to target the protein to treat metabolic disorders or obesity, he said.

The two new UT Southwestern studies outline for the first time the exact molecular mechanisms of PARP-1's roles in inhibiting the formation of fat cell precursors and in maintaining stem cells. Here are the key findings:

  • The first study identifies amino acids on C/EBPb (a key transcription factor required for formation) that are chemically modified by PARP-1's enzymatic activity through a process called ADP-ribosylation. Modification of C/EBPb interferes with the differentiation of precursor cells into fat , according to the study.
  • The second study reports how PARP-1 regulates embryonic stem cell self-renewal and pluripotency (ability to become different cell types), but without using its enzymatic activity. Instead, in this case, PARP-1 functions as a structural component of chromosomes in the nucleus, creating binding sites for the critical embryonic stem cell transcription factor Sox2. This action allows transcription of genes necessary to maintain the ability of to continue self-renewing, rather than becoming a specific cell type, the research shows.

Explore further: Expanded role of PARP proteins opens the door to explore therapeutic targets in cancer

Related Stories

Sleep proteins in new DNA repair mechanism

October 2, 2015

Researchers at Karolinska Institutet and universities in Hong Kong have found a new molecular mechanism for DNA repair involving an unexpected interaction between the PARP-1 protein and sleep proteins in humans. Their discovery ...

Recommended for you

Dogs detect breast cancer from bandage: researchers

March 24, 2017

Dogs can sniff out cancer from a piece of cloth which had touched the breast of a woman with a tumour, researchers said Friday, announcing the results of an unusual, but promising, diagnostic trial.

'Jumonji' protein key to Ewing's sarcoma rampage

March 24, 2017

By the time Ewing's Sarcoma is diagnosed, primarily in teens and young adults, it has often spread from its primary site to other parts of the body, making it difficult to treat. A University of Colorado Cancer Center study ...

In a sample of blood, researchers probe for cancer clues

March 24, 2017

One day, patients may be able to monitor their body's response to cancer therapy just by having their blood drawn. A new study, led by bioengineers at UC Berkeley, has taken an important step in that direction by measuring ...

Researchers gain insight into breast cancer drug resistance

March 24, 2017

Breast cancer's ability to develop resistance to treatment has frustrated researchers and physicians and has thwarted even the latest and greatest targeted therapies. For example, after researchers identified a disease pathway ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.